miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancerHao‐Yi Li(National Cheng Kung University), Pei‐Jung Lu(National Cheng Kung University Hospital)Breast Cancer ResearchDecember 1, 201710.1186/s13058-017-0918-2Cited by 170SaveCiteExport RISWatch citationsRelated PapersMiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma|Oncotarget|2016|34